Journal article
Dystrophin as a therapeutic biomarker: Are we ignoring data from the past?
Neuromuscular Disorders, Vol.24(6), pp.463-466
2014
Abstract
Dystrophin is a subsarcolemmal structural protein that provides a link between the actin cytoskeleton and a complex of proteins linked to the extracellular matrix. In the absence of dystrophin, muscle fibres are prone to damage and show altered contractile function and signaling deficits...
Details
- Title
- Dystrophin as a therapeutic biomarker: Are we ignoring data from the past?
- Authors/Creators
- S.D. Wilton (Author/Creator)S. Fletcher (Author/Creator)K.M. Flanigan (Author/Creator)
- Publication Details
- Neuromuscular Disorders, Vol.24(6), pp.463-466
- Publisher
- Elsevier BV
- Identifiers
- 991005541895707891
- Murdoch Affiliation
- Centre for Comparative Genomics
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
256 File views/ downloads
53 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.255 Musculoskeletal Disorders
- 1.255.628 Duchenne Muscular Dystrophy
- Web Of Science research areas
- Clinical Neurology
- Neurosciences
- ESI research areas
- Neuroscience & Behavior